FindMyKOL
Clinical trialNCT04460352RecruitingPhase 3Interventional

Chemoradiotherapy Followed by Planned Surgery or by Surveillance and Surgery Only When Needed for Oesophageal Cancer

SponsorKarolinska University HospitalEnrollment1,020Esophageal Squamous Cell Carcinoma
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

NEEDS is a pragmatic open-label, randomised, controlled, phase III, multicenter trial with non-inferiority design with regard to the first co-primary endpoint overall survival and superiority for the experimental intervention definitive chemoradiotherapy. A second co-primary endpoint is global health related quality of life (HRQOL) one year after randomisation. A third co-primary endpoint is eating restictions one year after randomisation. The aim is to compare outcomes after neoadjuvant chemoradiotherapy with subsequent esophagectomy to definitive chemoradiotherapy with surveillance and salvage esophagectomy as needed in patients with resectable locally advanced squamous cell carcinoma (SCC) of the esophagus, with the aim to provide generalisable guidance for future clinical practice.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada
  • Mcgill University Health Centre

    Montreal, Quebec, Canada

    Lorenzo Ferri, MD, PhD
    Recruiting
Ireland
  • Cancer Clinical Trials Unit (cctu) at St. James'S Hospital

    Dublin, Dublin, Ireland

    Grainne O'Kane, DrJohn Reynolds, ProfMoya Cunningham, Dr
    Recruiting
Norway
  • Oslo Universitetssykehus

    Oslo, Norway

    Ghazwan Al-Haidari, MD, PhD
    Recruiting
  • Universitetssykehuset Nord-Norge

    Tromsø, Norway

    Eirik Kjus Aahlin, MD, PhD
    Recruiting
  • St Olavs Hospital

    Trondheim, Norway

    Lars Cato Rekstad, MD, PhD
    Recruiting
Sweden
  • Linköpings Universitetssjukhus

    Linköping, Sweden

    Recruiting
  • Skånes Universitetssjukhus

    Lund, Sweden

    Jan Johansson, MD, PhD
    Recruiting
  • Karolinska University Hospital

    Stockholm, Sweden

    Gabriella Alexandersson von Döbeln, MD, PhDMagnus Nilsson, MD, PhD
    Recruiting
  • Norrlands Universitetssjukhus

    Umeå, Sweden

    Bengt Wallner, MD, PhD
    Recruiting
  • Akademiska Sjukhuset

    Uppsala, Sweden

    Jakob Hedberg, MD, PhD
    Recruiting
  • Örebro Universitetssjukhus

    Örebro, Sweden

    Eva Szabo, MD, PhD
    Recruiting
Taiwan
  • Chang Gung Memorial Hospital

    Linkou District, Taiwan

    Yinkai Chao, MD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
27 Nov 2020
Primary completion
31 Dec 2026
Completion
31 Dec 2031
Last update posted
6 Mar 2025
Registered enrollment
1,020
Registry id
NCT04460352

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.